Daniel Vitt

Chief Executive Officer at Immunic.

Raised on Immunic filings

$200M

of $200M offered across 1 Form D filing

Company

Biotech · New York, NY

Oral drugs for multiple sclerosis and colitis

Oral drugs for multiple sclerosis and colitis

Immunic Form D filings
Filed	Security	Sold of offered	Filing
Mar 4, 2026	Equity	$200M/ $200M	Form D

Also named on Immunic filings